NCT00337155View on ClinicalTrials.gov

BAY88-8223, Dose Finding Study in Patients With HRPC

PHASE2CompletedINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions

Prostate CancerNeoplasm Metastasis

Interventions

DRUG

Radium-223 dichloride (BAY88-8223)

3 doses of radium-223 at different dose levels, 25, 50 or 80 kBq/kg b.w.given as injection.

Trial Locations (1)

SM2 5RT

Sutton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY